Formulation and Optimization of Monolithic Fixed-Dose Combination of Metformin HCl and Glibenclamide Orodispersible Tablets

The treatment of type II DM involves the use of combination of drugs, especially at the chronic stage. However, the pill burden of this combination therapy combined with swallowing difficulties, occurring at a later stage of DM, has been the major challenge for successful treatment outcomes. This st...

Descripción completa

Detalles Bibliográficos
Autores principales: Belayneh, Anteneh, Molla, Fantahun, Kahsay, Getu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094173/
https://www.ncbi.nlm.nih.gov/pubmed/32259103
http://dx.doi.org/10.1155/2020/3546597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094173/
https://www.ncbi.nlm.nih.gov/pubmed/32259103
http://dx.doi.org/10.1155/2020/3546597

Ejemplares similares